Samrat Pharmachem standalone net profit declines 83.81% in the December 2023 quarter

Sales decline 26.45% to Rs 61.67 crore

Net profit of Samrat Pharmachem declined 83.81% to Rs 0.34 crore in the quarter ended December 2023 as against Rs 2.10 crore during the previous quarter ended December 2022. Sales declined 26.45% to Rs 61.67 crore in the quarter ended December 2023 as against Rs 83.85 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales61.6783.85 -26 OPM %0.183.91 -PBDT0.302.94 -90 PBT0.142.78 -95 NP0.342.10 -84

Powered by Capital Market - Live News